{
    "paper_id": "PMC7097328",
    "metadata": {
        "title": "Anti-infective monoclonal antibodies: perils and promise of development",
        "authors": [
            {
                "first": "Janice",
                "middle": [
                    "M."
                ],
                "last": "Reichert",
                "suffix": "",
                "email": "janice.reichert@tufts.edu",
                "affiliation": {}
            },
            {
                "first": "Matthew",
                "middle": [
                    "C."
                ],
                "last": "Dewitz",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Anti-infective monoclonal antibodies in Phase III studies or US-approved\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Targets for anti-infective monoclonal antibodies at three stages*\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: *Review to approval transitions were 100% for all cohorts, so transition probabilities for Phase III to FDA review and FDA review to approval were combined.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Monoclonal antibodies in the clinic",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Reichert",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Nature Biotechnol.",
            "volume": "19",
            "issn": "",
            "pages": "819-822",
            "other_ids": {
                "DOI": [
                    "10.1038/nbt0901-819"
                ]
            }
        },
        "BIBREF1": {
            "title": "Prospects for an AIDS vaccine: three big questions, no easy answers",
            "authors": [
                {
                    "first": "DA",
                    "middle": [],
                    "last": "Garber",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Silvestri",
                    "suffix": ""
                },
                {
                    "first": "MB",
                    "middle": [],
                    "last": "Feinberg",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lancet Infect. Dis.",
            "volume": "4",
            "issn": "",
            "pages": "397-413",
            "other_ids": {
                "DOI": [
                    "10.1016/S1473-3099(04)01056-4"
                ]
            }
        },
        "BIBREF2": {
            "title": "Can the pharmaceutical industry reduce attrition rates?",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Kola",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Landis",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Nature Rev. Drug Discov.",
            "volume": "3",
            "issn": "",
            "pages": "711-715",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd1470"
                ]
            }
        },
        "BIBREF3": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Bioshield hammered",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Usdin",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "BioCentury",
            "volume": "13(32)",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Therapeutic monoclonal antibodies: trends in development and approval in the US",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Reichert",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Curr. Opin. Mol. Ther.",
            "volume": "4",
            "issn": "",
            "pages": "110-118",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Monoclonal antibodies market",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Reichert",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pavlou",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Nature Rev. Drug Discov.",
            "volume": "3",
            "issn": "",
            "pages": "383-384",
            "other_ids": {
                "DOI": [
                    "10.1038/nrd1386"
                ]
            }
        },
        "BIBREF9": {
            "title": "Monoclonal antibody successes in the clinic",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Reichert",
                    "suffix": ""
                },
                {
                    "first": "CJ",
                    "middle": [],
                    "last": "Rosensweig",
                    "suffix": ""
                },
                {
                    "first": "LB",
                    "middle": [],
                    "last": "Faden",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Dewitz",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nature Biotechnol.",
            "volume": "23",
            "issn": "",
            "pages": "1073-1078",
            "other_ids": {
                "DOI": [
                    "10.1038/nbt0905-1073"
                ]
            }
        },
        "BIBREF10": {
            "title": "Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody",
            "authors": [
                {
                    "first": "RF",
                    "middle": [],
                    "last": "Hector",
                    "suffix": ""
                },
                {
                    "first": "MS",
                    "middle": [],
                    "last": "Collins",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Pennington",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "J. Infect. Dis.",
            "volume": "160",
            "issn": "",
            "pages": "483-489",
            "other_ids": {
                "DOI": [
                    "10.1093/infdis/160.3.483"
                ]
            }
        },
        "BIBREF11": {
            "title": "Human immune response to monoclonal antibodies",
            "authors": [
                {
                    "first": "MB",
                    "middle": [],
                    "last": "Khazaeli",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Conry",
                    "suffix": ""
                },
                {
                    "first": "AF",
                    "middle": [],
                    "last": "LoBuglio",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "J. Immunother.",
            "volume": "15",
            "issn": "",
            "pages": "42-52",
            "other_ids": {
                "DOI": [
                    "10.1097/00002371-199401000-00006"
                ]
            }
        },
        "BIBREF12": {
            "title": "E5 murine monoclonal antiendotoxin antibody in Gram-negative sepsis: a randomized controlled trial",
            "authors": [
                {
                    "first": "DC",
                    "middle": [],
                    "last": "Angus",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "JAMA",
            "volume": "283",
            "issn": "",
            "pages": "1723-1730",
            "other_ids": {
                "DOI": [
                    "10.1001/jama.283.13.1723"
                ]
            }
        },
        "BIBREF13": {
            "title": "Monoclonal antiendotoxin agent HA-1A (Centoxin)",
            "authors": [
                {
                    "first": "TJJ",
                    "middle": [],
                    "last": "Inglis",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Lancet",
            "volume": "341",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/0140-6736(93)92651-9"
                ]
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}